Sero-prevalence of rubella among pregnant women in India, 2017-Reference-Cited by-同舟云学术

Sero-prevalence of rubella among pregnant women in India, 2017

Published:2018-12 Issue:52 Volume:36 Page:7909-7912
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Muliyil Divya Elizabeth,Singh Pratibha,Jois Srinivas Krishna,Otiv Suhas,Suri Vanita,Varma Vishakha,Abraham Asha Mary,Raut Chandrakant,Gupta Minakshi,Singh Mini P.,Viswanathan Rajalakshmi,Naik Sadanand,Nag Vijaylakshmi,Benakappa Asha,Bavdekar Ashish,Sapkal Gajanan,Singh Kuldeep,Gupta Nivedita,Verma Sanjay,Santhanam Sridhar,Mishra Sudhir,Bhatnagar Ambar,Prasad G.R.V.,Kolekar Jyoti,Raj Naga,Sabarinathan R.,Sachdeva Ravinder Kaur,George Suji,Chaudhary Shyama^ORCID,Verghese Valsan Philip,Jagtap Vishal,Bharadwaj Manasa,Murhekar Manoj^ORCID

Funder

Gavi, the Vaccine Alliance

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference12 articles.

1. Rubella;Lambert;Lancet,2015

2. Rubella;Banatwala;Lancet,2004

3. World Health Organization, Regional office for South-East Asia. Strategic Plan for Measles Elimination and Rubella and Congenital Rubella Syndrome Control in the South-East Asia Region. Available at: http://www.searo.who.int/entity/immunization/documents/sear_mr_strategic_plan_2014_2020.pdf?ua=1.

4. WHO: Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011;86(29):301–16.

5. progress toward measles elimination—South-East Asia Region, 2003–2013;Thapa;MMWR Morb Mortal Wkly Rep,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022;Vaccine;2024-10

2. Identifying the population susceptible to rubella in Japan, 2020: Fine-scale risk mapping;Journal of Infection and Public Health;2024-06

3. Serosurvey of anti‐rubella and anti‐measles IgG antibodies in young females in Jahrom, southern west Iran in 2012: A review of literature of the serological profile in Iran;Journal of General and Family Medicine;2024-02-25

4. Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study;Vaccine;2023-10

5. Seroprevalence of rubella virus infection among antenatal care clients of Halaba Town public health facilities, southern Ethiopia;Scientific Reports;2023-05-03